Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190


Use of research evidence in state health policymaking: Menu labeling policy in California.

Payán DD, Lewis LB.

Prev Med Rep. 2019 Oct 21;16:101004. doi: 10.1016/j.pmedr.2019.101004. eCollection 2019 Dec.


Church-based interventions to address obesity among African Americans and Latinos in the United States: a systematic review.

Flórez KR, Payán DD, Palar K, Williams MV, Katic B, Derose KP.

Nutr Rev. 2019 Sep 20. pii: nuz046. doi: 10.1093/nutrit/nuz046. [Epub ahead of print]


Discovery of novel bacterial queuine salvage enzymes and pathways in human pathogens.

Yuan Y, Zallot R, Grove TL, Payan DJ, Martin-Verstraete I, Šepić S, Balamkundu S, Neelakandan R, Gadi VK, Liu CF, Swairjo MA, Dedon PC, Almo SC, Gerlt JA, de Crécy-Lagard V.

Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):19126-19135. doi: 10.1073/pnas.1909604116. Epub 2019 Sep 3.


Feasibility and acceptability of a mobile messaging program within a church-based healthy living intervention for African Americans and Latinos.

Whitley MD, Payán DD, Flórez KR, Williams MV, Wong EC, Branch CA, Derose KP.

Health Informatics J. 2019 Jun 15:1460458219853408. doi: 10.1177/1460458219853408. [Epub ahead of print]


"It Was as Though My Spirit Left, Like They Killed Me": The Disruptive Impact of an HIV-Positive Diagnosis among Women in the Dominican Republic.

Payán DD, Derose KP, Fulcar MA, Farías H, Palar K.

J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219849042. doi: 10.1177/2325958219849042.


Eat, Pray, Move: A Pilot Cluster Randomized Controlled Trial of a Multilevel Church-Based Intervention to Address Obesity Among African Americans and Latinos.

Derose KP, Williams MV, Flórez KR, Griffin BA, Payán DD, Seelam R, Branch CA, Hawes-Dawson J, Mata MA, Whitley MD, Wong EC.

Am J Health Promot. 2019 May;33(4):586-596. doi: 10.1177/0890117118813333. Epub 2018 Nov 25.


Intrapersonal and Environmental Barriers to Physical Activity Among Blacks and Latinos.

Payán DD, Sloane DC, Illum J, Lewis LB.

J Nutr Educ Behav. 2019 Apr;51(4):478-485. doi: 10.1016/j.jneb.2018.10.001. Epub 2018 Nov 13.


Promoting Health from the Pulpit: A Process Evaluation of HIV Sermons to Reduce HIV Stigma and Promote Testing in African American and Latino Churches.

Payán DD, Flórez KR, Bogart LM, Kanouse DE, Mata MA, Oden CW, Derose KP.

Health Commun. 2019 Jan;34(1):11-20. doi: 10.1080/10410236.2017.1384352. Epub 2017 Oct 20.


Perceived Barriers and Facilitators to Healthy Eating and School Lunch Meals among Adolescents: A Qualitative Study.

Payán DD, Sloane DC, Illum J, Farris T, Lewis LB.

Am J Health Behav. 2017 Sep 1;41(5):661-669. doi: 10.5993/AJHB.41.5.15.


Process Evaluation of a Peer-Driven, HIV Stigma Reduction and HIV Testing Intervention in Latino and African American Churches.

Flórez KR, Payán DD, Derose KP, Aunon FM, Bogart LM.

Health Equity. 2017 Aug 1;1(1):109-117. doi: 10.1089/heq.2017.0009. eCollection 2017.


Factors contributing to food insecurity among women living with HIV in the Dominican Republic: A qualitative study.

Derose KP, Payán DD, Fulcar MA, Terrero S, Acevedo R, Farías H, Palar K.

PLoS One. 2017 Jul 25;12(7):e0181568. doi: 10.1371/journal.pone.0181568. eCollection 2017.


Severe food insecurity is associated with overweight and increased body fat among people living with HIV in the Dominican Republic.

Derose KP, Ríos-Castillo I, Fulcar MA, Payán DD, Palar K, Escala L, Farías H, Martínez H.

AIDS Care. 2018 Feb;30(2):182-190. doi: 10.1080/09540121.2017.1348597. Epub 2017 Jul 6.


Catalyzing Implementation of Evidence-Based Interventions in Safety Net Settings: A Clinical-Community Partnership in South Los Angeles.

Payán DD, Sloane DC, Illum J, Vargas RB, Lee D, Galloway-Gilliam L, Lewis LB.

Health Promot Pract. 2017 Jul;18(4):586-597. doi: 10.1177/1524839917705418. Epub 2017 Apr 26.


Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus.

Shaw SJ, Goff DA, Lin N, Singh R, Li W, McLaughlin J, Baltgalvis KA, Payan DG, Kinsella TM.

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2617-2621. doi: 10.1016/j.bmcl.2017.03.037. Epub 2017 Mar 18.


Advocacy coalitions involved in California's menu labeling policy debate: Exploring coalition structure, policy beliefs, resources, and strategies.

Payán DD, Lewis LB, Cousineau MR, Nichol MB.

Soc Sci Med. 2017 Mar;177:78-86. doi: 10.1016/j.socscimed.2017.01.036. Epub 2017 Jan 25.


Janus kinase inhibition prevents cancer- and myocardial infarction-mediated diaphragm muscle weakness in mice.

Smith IJ, Roberts B, Beharry A, Godinez GL, Payan DG, Kinsella TM, Judge AR, Ferreira LF.

Am J Physiol Regul Integr Comp Physiol. 2016 Apr 15;310(8):R707-10. doi: 10.1152/ajpregu.00550.2015. Epub 2016 Feb 10.


Developing structure-activity relationships from an HTS hit for inhibition of the Cks1-Skp2 protein-protein interaction.

Singh R, Sran A, Carroll DC, Huang J, Tsvetkov L, Zhou X, Sheung J, McLaughlin J, Issakani SD, Payan DG, Shaw SJ.

Bioorg Med Chem Lett. 2015 Nov 15;25(22):5199-202. doi: 10.1016/j.bmcl.2015.09.067. Epub 2015 Sep 30.


Design, synthesis of diaminopyrimidine inhibitors targeting IgE- and IgG-mediated activation of Fc receptor signaling.

Argade A, Bhamidipati S, Li H, Sylvain C, Clough J, Carroll D, Keim H, Braselmann S, Taylor V, Zhao H, Herlaar E, Issakani SD, Wong BR, Masuda ES, Payan DG, Singh R.

Bioorg Med Chem Lett. 2015;25(10):2122-8. doi: 10.1016/j.bmcl.2015.03.072. Epub 2015 Apr 1.


Application of cultured human mast cells (CHMC) for the design and structure-activity relationship of IgE-mediated mast cell activation inhibitors.

Argade A, Bhamidipati S, Li H, Carroll D, Clough J, Keim H, Sylvain C, Rossi AB, Coquilla C, Issakani SD, Masuda ES, Payan DG, Singh R.

Bioorg Med Chem Lett. 2015;25(10):2117-21. doi: 10.1016/j.bmcl.2015.03.075. Epub 2015 Mar 31.


The JAK-STAT pathway is critical in ventilator-induced diaphragm dysfunction.

Tang H, Smith IJ, Hussain SN, Goldberg P, Lee M, Sugiarto S, Godinez GL, Singh BK, Payan DG, Rando TA, Kinsella TM, Shrager JB.

Mol Med. 2015 Feb 19;20:579-89. doi: 10.2119/molmed.2014.00049.


Global metabolite profiling of mice with high-fat diet-induced obesity chronically treated with AMPK activators R118 or metformin reveals tissue-selective alterations in metabolic pathways.

Jenkins Y, Sun TQ, Li Y, Markovtsov V, Uy G, Gross L, Goff DA, Shaw SJ, Boralsky L, Singh R, Payan DG, Hitoshi Y.

BMC Res Notes. 2014 Sep 25;7:674. doi: 10.1186/1756-0500-7-674.


Targeting autoimmunity: strategies and tactics.

Masuda ES, Payan DG.

Drug Discov Today. 2014 Aug;19(8):1193-4. doi: 10.1016/j.drudis.2014.05.024. Epub 2014 Jun 2. No abstract available.


Noninvasive imaging of in vivo MuRF1 expression during muscle atrophy.

Li W, Claypool MD, Friera AM, McLaughlin J, Baltgalvis KA, Smith IJ, Kinoshita T, White K, Lang W, Godinez G, Payan DG, Kinsella TM.

PLoS One. 2014 Apr 7;9(4):e94032. doi: 10.1371/journal.pone.0094032. eCollection 2014.


Inhibition of Janus kinase signaling during controlled mechanical ventilation prevents ventilation-induced diaphragm dysfunction.

Smith IJ, Godinez GL, Singh BK, McCaughey KM, Alcantara RR, Gururaja T, Ho MS, Nguyen HN, Friera AM, White KA, McLaughlin JR, Hansen D, Romero JM, Baltgalvis KA, Claypool MD, Li W, Lang W, Yam GC, Gelman MS, Ding R, Yung SL, Creger DP, Chen Y, Singh R, Smuder AJ, Wiggs MP, Kwon OS, Sollanek KJ, Powers SK, Masuda ES, Taylor VC, Payan DG, Kinoshita T, Kinsella TM.

FASEB J. 2014 Jul;28(7):2790-803. doi: 10.1096/fj.13-244210. Epub 2014 Mar 26.


Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.

Baltgalvis KA, White K, Li W, Claypool MD, Lang W, Alcantara R, Singh BK, Friera AM, McLaughlin J, Hansen D, McCaughey K, Nguyen H, Smith IJ, Godinez G, Shaw SJ, Goff D, Singh R, Markovtsov V, Sun TQ, Jenkins Y, Uy G, Li Y, Pan A, Gururaja T, Lau D, Park G, Hitoshi Y, Payan DG, Kinsella TM.

Am J Physiol Heart Circ Physiol. 2014 Apr 15;306(8):H1128-45. doi: 10.1152/ajpheart.00839.2013. Epub 2014 Feb 21.


AMPK activation through mitochondrial regulation results in increased substrate oxidation and improved metabolic parameters in models of diabetes.

Jenkins Y, Sun TQ, Markovtsov V, Foretz M, Li W, Nguyen H, Li Y, Pan A, Uy G, Gross L, Baltgalvis K, Yung SL, Gururaja T, Kinoshita T, Owyang A, Smith IJ, McCaughey K, White K, Godinez G, Alcantara R, Choy C, Ren H, Basile R, Sweeny DJ, Xu X, Issakani SD, Carroll DC, Goff DA, Shaw SJ, Singh R, Boros LG, Laplante MA, Marcotte B, Kohen R, Viollet B, Marette A, Payan DG, Kinsella TM, Hitoshi Y.

PLoS One. 2013 Dec 5;8(12):e81870. doi: 10.1371/journal.pone.0081870. eCollection 2013.


Discovery and development of spleen tyrosine kinase (SYK) inhibitors.

Singh R, Masuda ES, Payan DG.

J Med Chem. 2012 Apr 26;55(8):3614-43. doi: 10.1021/jm201271b. Epub 2012 Feb 14. No abstract available.


R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm.

Shide K, Kameda T, Markovtsov V, Shimoda HK, Tonkin E, Fang S, Liu C, Gelman M, Lang W, Romero J, McLaughlin J, Bhamidipati S, Clough J, Low C, Reitsma A, Siu S, Pine P, Park G, Torneros A, Duan M, Singh R, Payan DG, Matsunaga T, Hitoshi Y, Shimoda K.

Blood. 2011 Jun 23;117(25):6866-75. doi: 10.1182/blood-2010-01-262535. Epub 2011 Apr 29.


The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases.

Hitoshi Y, Lin N, Payan DG, Markovtsov V.

Int J Hematol. 2010 Mar;91(2):189-200. doi: 10.1007/s12185-010-0531-y. Epub 2010 Feb 27. Review. Erratum in: Int J Hematol. 2010 Apr;91(3):555.


R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.

Holland SJ, Pan A, Franci C, Hu Y, Chang B, Li W, Duan M, Torneros A, Yu J, Heckrodt TJ, Zhang J, Ding P, Apatira A, Chua J, Brandt R, Pine P, Goff D, Singh R, Payan DG, Hitoshi Y.

Cancer Res. 2010 Feb 15;70(4):1544-54. doi: 10.1158/0008-5472.CAN-09-2997. Epub 2010 Feb 9.


Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen.

McLaughlin J, Markovtsov V, Li H, Wong S, Gelman M, Zhu Y, Franci C, Lang D, Pali E, Lasaga J, Low C, Zhao F, Chang B, Gururaja TL, Xu W, Baluom M, Sweeny D, Carroll D, Sran A, Thota S, Parmer M, Romane A, Clemens G, Grossbard E, Qu K, Jenkins Y, Kinoshita T, Taylor V, Holland SJ, Argade A, Singh R, Pine P, Payan DG, Hitoshi Y.

J Cancer Res Clin Oncol. 2010 Jan;136(1):99-113. doi: 10.1007/s00432-009-0641-1.


JAK3 inhibition significantly attenuates psoriasiform skin inflammation in CD18 mutant PL/J mice.

Chang BY, Zhao F, He X, Ren H, Braselmann S, Taylor V, Wicks J, Payan DG, Grossbard EB, Pine PR, Bullard DC.

J Immunol. 2009 Aug 1;183(3):2183-92. doi: 10.4049/jimmunol.0804063. Epub 2009 Jul 13.


Discovery and development of an aurora kinase inhibitor clinical candidate using an image-based assay for measuring proliferation, apoptosis, and DNA content.

Catalano SM, McLaughlin J, Hitoshi Y, Payan D.

Assay Drug Dev Technol. 2009 Apr;7(2):180-90. doi: 10.1089/adt.2007.086.


Approaches to discovering drugs that regulate E3 ubiquitin ligases.

Huang J, Tsvetkov L, Qu K, Daniel-Issakani S, Payan DG.

Ernst Schering Found Symp Proc. 2008;(1):153-70.


An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.

Bahjat FR, Pine PR, Reitsma A, Cassafer G, Baluom M, Grillo S, Chang B, Zhao FF, Payan DG, Grossbard EB, Daikh DI.

Arthritis Rheum. 2008 May;58(5):1433-44. doi: 10.1002/art.23428.


Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication.

Huang P, Goff DA, Huang Q, Martinez A, Xu X, Crowder S, Issakani SD, Anderson E, Sheng N, Achacoso P, Yen A, Kinsella T, Darwish IS, Kolluri R, Hong H, Qu K, Stauffer E, Goldstein E, Singh R, Payan DG, Lu HH.

Antimicrob Agents Chemother. 2008 Apr;52(4):1419-29. doi: 10.1128/AAC.00525-07. Epub 2008 Jan 28.


A class of small molecules that inhibit TNFalpha-induced survival and death pathways via prevention of interactions between TNFalphaRI, TRADD, and RIP1.

Gururaja TL, Yung S, Ding R, Huang J, Zhou X, McLaughlin J, Daniel-Issakani S, Singh R, Cooper RD, Payan DG, Masuda ES, Kinoshita T.

Chem Biol. 2007 Oct;14(10):1105-18.


Substrate modification with lysine 63-linked ubiquitin chains through the UBC13-UEV1A ubiquitin-conjugating enzyme.

Petroski MD, Zhou X, Dong G, Daniel-Issakani S, Payan DG, Huang J.

J Biol Chem. 2007 Oct 12;282(41):29936-45. Epub 2007 Aug 20.


Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor.

Pine PR, Chang B, Schoettler N, Banquerigo ML, Wang S, Lau A, Zhao F, Grossbard EB, Payan DG, Brahn E.

Clin Immunol. 2007 Sep;124(3):244-57. Epub 2007 May 29.


Identification of the Syk kinase inhibitor R112 by a human mast cell screen.

Rossi AB, Herlaar E, Braselmann S, Huynh S, Taylor V, Frances R, Issakani SD, Argade A, Singh R, Payan DG, Masuda ES.

J Allergy Clin Immunol. 2006 Sep;118(3):749-55. Epub 2006 Jul 28.


R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.

Braselmann S, Taylor V, Zhao H, Wang S, Sylvain C, Baluom M, Qu K, Herlaar E, Lau A, Young C, Wong BR, Lovell S, Sun T, Park G, Argade A, Jurcevic S, Pine P, Singh R, Grossbard EB, Payan DG, Masuda ES.

J Pharmacol Exp Ther. 2006 Dec;319(3):998-1008. Epub 2006 Aug 31. Erratum in: J Pharmacol Exp Ther. 2013 May;345(2):326.


R-253 disrupts microtubule networks in multiple tumor cell lines.

Gururaja TL, Goff D, Kinoshita T, Goldstein E, Yung S, McLaughlin J, Pali E, Huang J, Singh R, Daniel-Issakani S, Hitoshi Y, Cooper RD, Payan DG.

Clin Cancer Res. 2006 Jun 15;12(12):3831-42.


High-throughput screening for inhibitors of the e3 ubiquitin ligase APC.

Huang J, Sheung J, Dong G, Coquilla C, Daniel-Issakani S, Payan DG.

Methods Enzymol. 2005;399:740-54.


A homogeneous FRET assay system for multiubiquitin chain assembly and disassembly.

Gururaja TL, Pray TR, Lowe R, Dong G, Huang J, Daniel-Issakani S, Payan DG.

Methods Enzymol. 2005;399:663-82.


Multiple roles for the receptor tyrosine kinase axl in tumor formation.

Holland SJ, Powell MJ, Franci C, Chan EW, Friera AM, Atchison RE, McLaughlin J, Swift SE, Pali ES, Yam G, Wong S, Lasaga J, Shen MR, Yu S, Xu W, Hitoshi Y, Bogenberger J, Nör JE, Payan DG, Lorens JB.

Cancer Res. 2005 Oct 15;65(20):9294-303.


Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth.

Jenkins Y, Markovtsov V, Lang W, Sharma P, Pearsall D, Warner J, Franci C, Huang B, Huang J, Yam GC, Vistan JP, Pali E, Vialard J, Janicot M, Lorens JB, Payan DG, Hitoshi Y.

Mol Biol Cell. 2005 Dec;16(12):5621-9. Epub 2005 Sep 29.


A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation.

Zhao H, Li CC, Pardo J, Chu PC, Liao CX, Huang J, Dong JG, Zhou X, Huang Q, Huang B, Bennett MK, Molineaux SM, Lu H, Daniel-Issakani S, Payan DG, Masuda ES.

J Immunol. 2005 May 1;174(9):5288-97.


The poxvirus p28 virulence factor is an E3 ubiquitin ligase.

Huang J, Huang Q, Zhou X, Shen MM, Yen A, Yu SX, Dong G, Qu K, Huang P, Anderson EM, Daniel-Issakani S, Buller RM, Payan DG, Lu HH.

J Biol Chem. 2004 Dec 24;279(52):54110-6. Epub 2004 Oct 20.


Riboproteomics of the hepatitis C virus internal ribosomal entry site.

Lu H, Li W, Noble WS, Payan D, Anderson DC.

J Proteome Res. 2004 Sep-Oct;3(5):949-57.


Supplemental Content

Support Center